bluebird bioRecent Data Breaches and Security Report

https://bluebirdbio.com  ᛫  Biotech & Pharmaceuticals
Last updated October 26, 2018

Company Details

Company Overview

bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. Our objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.

Valuation

Employees

CEO

Nick Leschly

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like bluebird bio

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for bluebird bio

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.